A Randomized Placebo-Controlled Phase Ia Malaria Vaccine Trial of Two Virosome-Formulated Synthetic Peptides in Healthy Adult Volunteers

• Blaise Genton ,

  Contributed equally to this work with: Blaise Genton, Gerd Pluschke

  *To whom correspondence should be addressed. E-mail: blaise.genton@unibas.ch

  Affiliation Swiss Tropical Institute, Basel, Switzerland

  ⨯
• Gerd Pluschke ,

  Contributed equally to this work with: Blaise Genton, Gerd Pluschke

  Affiliation Swiss Tropical Institute, Basel, Switzerland

  ⨯
• Lukas Degen,

  Affiliation Clinical Research Center, University Hospital, Basel, Switzerland

  ⨯
• Andreas R. Kammer,

  Affiliation Pevion Biotech Ltd., Bern, Switzerland

  ⨯
• Nicole Westerfeld,

  Affiliation Pevion Biotech Ltd., Bern, Switzerland

  ⨯
• Shinji L. Okitsu,

  Affiliation Swiss Tropical Institute, Basel, Switzerland

  ⨯
• Sandro Schroller,

  Affiliation Clinical Research Center, University Hospital, Basel, Switzerland

  ⨯
• Penelope Vounatsou,

  Affiliation Swiss Tropical Institute, Basel, Switzerland

  ⨯
• Markus M. Mueller,

  Affiliation Swiss Tropical Institute, Basel, Switzerland

  ⨯
• Marcel Tanner,

  Affiliation Swiss Tropical Institute, Basel, Switzerland

  ⨯
• Rinaldo Zurbriggen

  Affiliation Pevion Biotech Ltd., Bern, Switzerland

  ⨯